BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16549462)

  • 1. Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.
    Jonkers IJ; Smelt AH; Princen HM; Kuipers F; Romijn JA; Boverhof R; Masclee AA; Stellaard F
    J Nutr; 2006 Apr; 136(4):987-91. PubMed ID: 16549462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.
    Jonkers IJ; Smelt AH; Ledeboer M; Hollum ME; Biemond I; Kuipers F; Stellaard F; Boverhof R; Meinders AE; Lamers CH; Masclee AA
    Gut; 2003 Jan; 52(1):109-15. PubMed ID: 12477770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy.
    Jonkers IJ; Smelt AH; Hattori H; Scheek LM; van Gent T; de Man FH; van der Laarse A; van Tol A
    J Lipid Res; 2003 Aug; 44(8):1462-9. PubMed ID: 12754275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.
    Jonkers IJ; Mohrschladt MF; Westendorp RG; van der Laarse A; Smelt AH
    Am J Med; 2002 Mar; 112(4):275-80. PubMed ID: 11893366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.
    de Man FH; Jonkers IJ; Schwedhelm E; Smelt AH; Onkenhout W; van Duyvenvoorde W; Buytenhek R; Leuven JA; Troost R; van Der Laarse A; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2434-40. PubMed ID: 11073849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia: associated risks and effect of drug treatment.
    Jonkers IJ; Smelt AH; van der Laarse A
    Am J Cardiovasc Drugs; 2001; 1(6):455-66. PubMed ID: 14728004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serum triglyceride levels and different lipid-lowering methods on the prognosis of hypertriglyceridemic acute pancreatitis: a single-center 12-year retrospective study by propensity score matching.
    Liu Y; Cheng JP; Zhao XL
    Scand J Gastroenterol; 2024 Jul; 59(7):843-851. PubMed ID: 38625376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia.
    Krysiak R; Gdula-Dymek A; Okopien B
    Eur J Clin Pharmacol; 2011 Nov; 67(11):1109-17. PubMed ID: 21630032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene.
    Raposo HF; Patrício PR; Simões MC; Oliveira HC
    J Nutr Biochem; 2014 Jun; 25(6):669-74. PubMed ID: 24746832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus.
    Yamaguchi T; Shirai K; Nagayama D; Nakamura S; Oka R; Tanaka S; Watanabe Y; Imamura H; Sato Y; Kawana H; Ohira M; Saiki A; Shimizu N; Tatsuno I
    J Atheroscler Thromb; 2019 Jul; 26(7):659-669. PubMed ID: 30584220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
    Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the hypolipidemic effect of fish oil by inhibition of adipose tissue lipolysis with acipimox, a nicotinic acid analog.
    Seböková E; Klimes I; Hermann M; Minchenko A; Mitková A; Hromadová M
    Ann N Y Acad Sci; 1993 Jun; 683():183-91. PubMed ID: 8102515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibric acids: effects on lipids and lipoprotein metabolism.
    Grundy SM; Vega GL
    Am J Med; 1987 Nov; 83(5B):9-20. PubMed ID: 3318457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man.
    Einarsson K; Grundy SM
    J Lipid Res; 1980 Jan; 21(1):23-34. PubMed ID: 7354252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects on renal function and glucose metabolism of renal dependent bezafibrate and non-renal dependent pemafibrate in patients with hypertriglyceridemia.
    Nishida M; Horio T; Fukuda Y; Hayakawa Y; Tateishi Y; Akai M; Emoto M; Hasegawa T; Imanishi M
    Int J Clin Pharmacol Ther; 2023 Oct; 61(10):437-444. PubMed ID: 37548458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.
    de Man FH; Nieuwland R; van der Laarse A; Romijn F; Smelt AH; Gevers Leuven JA; Sturk A
    Atherosclerosis; 2000 Oct; 152(2):407-14. PubMed ID: 10998469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
    Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
    Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.
    Koopal C; Marais AD; Westerink J; van der Graaf Y; Visseren FLJ
    J Lipid Res; 2017 Nov; 58(11):2180-2187. PubMed ID: 28928170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.